^
Association details:
| Biomarker: | PD-L1 elevation |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug: | Opdivo (nivolumab) (PD1 inhibitor) |
| Direction: | Resistant |
Evidence:
Source:
Title:
Association between soluble PD-L1 and prognosis of non-small cell lung cancer (NSCLC) patients treated with immunotherapy
Published date:
09/14/2020
Excerpt:
We explored correlations between sPD-L1 and clinical outcomes of Pembro cohort and Nivo cohort. In Nivo cohort, sPD-L1 was not associated with clinical outcomes. sPD-L1 was not prognostic for pre-treated patients receiving Nivo.
